Goserelin (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Goserelin" in English language version.

refsWebsite

Global rank English rank

4^th place

2^nd place

3^rd place

1,712^th place

1,063^rd place

102^nd place

76^th place

8,573^rd place

low place

books.google.com

Dittrich R, Binder H, Cupisti S, Hoffmann I, Beckmann MW, Mueller A (December 2005). "Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist". Experimental and Clinical Endocrinology & Diabetes. 113 (10): 586–92. doi:10.1055/s-2005-865900. PMID 16320157.
Di Lorenzo G, Autorino R, Perdonà S, De Placido S (December 2005). "Management of gynaecomastia in patients with prostate cancer: a systematic review". The Lancet. Oncology. 6 (12): 972–979. doi:10.1016/S1470-2045(05)70464-2. PMID 16321765.
Friedman AJ, Juneau-Norcross M, Rein MS (February 1993). "Adverse effects of leuprolide acetate depot treatment". Fertility and Sterility. 59 (2): 448–50. doi:10.1016/s0015-0282(16)55701-x. PMID 8425646.
Kotake T, Usami M, Akaza H, Koiso K, Homma Y, Kawabe K, et al. (November 1999). "Goserelin acetate with or without antiandrogen or estrogen in the treatment of patients with advanced prostate cancer: a multicenter, randomized, controlled trial in Japan. Zoladex Study Group". Japanese Journal of Clinical Oncology. 29 (11): 562–570. doi:10.1093/jjco/29.11.562. PMID 10678560.

World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization. hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.

Dittrich R, Binder H, Cupisti S, Hoffmann I, Beckmann MW, Mueller A (December 2005). "Endocrine treatment of male-to-female transsexuals using gonadotropin-releasing hormone agonist". Experimental and Clinical Endocrinology & Diabetes. 113 (10): 586–92. doi:10.1055/s-2005-865900. PMID 16320157.
Di Lorenzo G, Autorino R, Perdonà S, De Placido S (December 2005). "Management of gynaecomastia in patients with prostate cancer: a systematic review". The Lancet. Oncology. 6 (12): 972–979. doi:10.1016/S1470-2045(05)70464-2. PMID 16321765.
Friedman AJ, Juneau-Norcross M, Rein MS (February 1993). "Adverse effects of leuprolide acetate depot treatment". Fertility and Sterility. 59 (2): 448–50. doi:10.1016/s0015-0282(16)55701-x. PMID 8425646.
Kotake T, Usami M, Akaza H, Koiso K, Homma Y, Kawabe K, et al. (November 1999). "Goserelin acetate with or without antiandrogen or estrogen in the treatment of patients with advanced prostate cancer: a multicenter, randomized, controlled trial in Japan. Zoladex Study Group". Japanese Journal of Clinical Oncology. 29 (11): 562–570. doi:10.1093/jjco/29.11.562. PMID 10678560.